When less is better, but physicians are afraid not to intervene

JAMA Internal Medicine

Volumn 176, Issue 7, 2016, Pages 888-889

  Esserman, Laura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; DECISION MAKING; HUMAN; INTRADUCTAL CARCINOMA; NOTE; PATIENT PREFERENCE; PRIORITY JOURNAL; TUMOR INVASION; PHYSICIAN;

HUMANS; PHYSICIANS;

EID: 84978972749     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.2257     Document Type: Note

References (8)

1. Harris JV. Ductal carcinoma in situ stage 0 breast cancer: when less may be better [published onlineMay 31, 2016]. JAMA Intern Med. doi:10.1001/jamainternmed.2016.2254.
2. Borowsky A, Esserman L. When the gold standard loses its luster, perhaps it is time to change nomenclature [published online March 22, 2016]. Ann Intern Med. 2016. doi:10.7326/M16-0526.
3. Sagara Y, Mallory MA, Wong S, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: A population-based cohort study. JAMA Surg. 2015;150(8):739-745.
4. Goss PE, Ingle JN, Alés Martínez JE, et al; NCIC CTG MAP.3 Study Investigators. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011;364(25):2381-2391.
5. Vogel VG, Costantino JP, Wickerham DL, et al; National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295(23):2727-2741.
6. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005;97(22):1652-1662.
7. Shieh Y, Eklund M, Esserman L. Detection of ductal carcinoma in situ and subsequent interval cancers. BMJ. 2016;352:i551.
8. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1(7):888-896.